default author photo

Junping Zhang

Shanxi Bethune Hospital - Department of Cancer Biotherapy

Taiyuan

China

SCHOLARLY PAPERS

2

DOWNLOADS

245

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Randomized, Multicenter, Open-Label Trial of Autologous Cytokine-Induced Killer Cell Immunotherapy Plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer

Number of pages: 57 Posted: 25 Feb 2020
Tianjin Medical University - Tianjin’s Clinical Research Center for Cancer, Zhengzhou University - Department of Immunology, Soochow University - Tumor Biological Diagnosis and Treatment Center, Shanxi Bethune Hospital - Department of Cancer Biotherapy, Kunming Medical University, Jilin University (JLU) - Cancer Center, Fujian Medical University - Fujian Cancer Hospital, Hebei Medical University - Department of Immune-Oncology, Kunming Medical University, Tianjin Medical University - Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, Zhengzhou University - Department of Immunotherapy, Zhengzhou University - Department of Immunotherapy, Soochow University - Department of Tumor Biological Treatment, Soochow University - Department of Tumor Biological Treatment, Shanxi Bethune Hospital - Department of Oncology, Shanxi Bethune Hospital - Department of Oncology, Kunming Medical University - Cancer Biotherapy Center, Jilin University (JLU) - Cancer Center, Jilin University (JLU) - Cancer Center, Fujian Medical University - Laboratory of Immuno-Oncology, Kawasaki Medical School - Department of Immuno-Oncology, Tianjin Medical University - Tianjin’s Clinical Research Center for Cancer, Tianjin Medical University - Tianjin’s Clinical Research Center for Cancer and Tianjin Medical University - Immunology Laboratory
Downloads 162 (461,984)

Abstract:

Loading...

NSCLC; Cytokine-induced killer cell; Immunotherapy; Prognosis

2.

Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study

Number of pages: 55 Posted: 18 Aug 2020
Shanghai Jiao Tong University (SJTU) - Shanghai Lung Cancer Center, Jilin University (JLU) - Cancer Center, Guangzhou Medical University - State Key Laboratory of Respiratory Disease, Geneplus-Beijing Co. Ltd., Shantou University - Cancer Hospital, Wenzhou Medical University - Second Affiliated Hospital, Nanchang University - Department of Radiation Oncology, Shanxi Bethune Hospital - Department of Cancer Biotherapy, Shanxi Tumor Hospital - Department of Respiratory - Ward One, Shanghai Jiao Tong University (SJTU) - Department of Oncology, Zhejiang Shuren University - Department of Thoracic Oncology, Ningbo Second Hospital - Radiotherapy and Chemotherapy Department 2, Government of the People's Republic of China - Department of Medical Oncology, Guangxi Medical University - Department of Medical Oncology of Respirotary, Geneplus-Beijing Co. Ltd., Geneplus-Beijing Co. Ltd., Geneplus-Beijing Co. Ltd. and Shanghai Jiao Tong University (SJTU) - Shanghai Lung Cancer Center
Downloads 83 (783,685)

Abstract:

Loading...

clonal architecture, EGFR, NSCLC, ctDNA